My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 247

    1.

    Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: a case series.

    McLaughlin VV, Genthner DE, Panella MM, Hess DM, Rich S.

    Ann Intern Med. 1999 May 4;130(9):740-3.PMID: 10357693 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin.

    Barst RJ, Rubin LJ, McGoon MD, Caldwell EJ, Long WA, Levy PS.

    Ann Intern Med. 1994 Sep 15;121(6):409-15.PMID: 8053614 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.

    Badesch DB, Tapson VF, McGoon MD, Brundage BH, Rubin LJ, Wigley FM, Rich S, Barst RJ, Barrett PS, Kral KM, Jöbsis MM, Loyd JE, Murali S, Frost A, Girgis R, Bourge RC, Ralph DD, Elliott CG, Hill NS, Langleben D, Schilz RJ, McLaughlin VV, Robbins IM, Groves BM, Shapiro S, Medsger TA Jr.

    Ann Intern Med. 2000 Mar 21;132(6):425-34.PMID: 10733441 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Successful use of continuous intravenous prostacyclin in a patient with severe portopulmonary hypertension.

    Kähler CM, Graziadei I, Wiedermann CJ, Kneussl MP, Vogel W.

    Wien Klin Wochenschr. 2000 Jul 28;112(14):637-40.PMID: 11008327 [PubMed - indexed for MEDLINE]Related articles

    5.

    Aerosolized prostacyclin and iloprost in severe pulmonary hypertension.

    Olschewski H, Walmrath D, Schermuly R, Ghofrani A, Grimminger F, Seeger W.

    Ann Intern Med. 1996 May 1;124(9):820-4.PMID: 8610951 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    [Long-term experience with trerpostinil infusion treatment in patients with pulmonary arterial hypertension in the Czech Republic]

    Jansa P, Ambroz D, Maresová J, Jelínková L, Polácek P, Palecek T, Aschermann M, Linhart A.

    Vnitr Lek. 2007 Apr;53(4):333-7. Czech. PMID: 17578162 [PubMed - indexed for MEDLINE]Related articles

    7.

    Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial.

    Simonneau G, Rubin LJ, Galiè N, Barst RJ, Fleming TR, Frost AE, Engel PJ, Kramer MR, Burgess G, Collings L, Cossons N, Sitbon O, Badesch DB; PACES Study Group.

    Ann Intern Med. 2008 Oct 21;149(8):521-30. Erratum in: Ann Intern Med. 2009 Jan 6;150(1):63. Ann Intern Med. 2009 Sep 15;151(6):435. PMID: 18936500 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension.

    Cabrol S, Souza R, Jais X, Fadel E, Ali RH, Humbert M, Dartevelle P, Simonneau G, Sitbon O.

    J Heart Lung Transplant. 2007 Apr;26(4):357-62.PMID: 17403477 [PubMed - indexed for MEDLINE]Related articles

    9.

    Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial.

    Rubin LJ, Mendoza J, Hood M, McGoon M, Barst R, Williams WB, Diehl JH, Crow J, Long W.

    Ann Intern Med. 1990 Apr 1;112(7):485-91.PMID: 2107780 [PubMed - indexed for MEDLINE]Related articles

    10.

    Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.

    Sitbon O, Humbert M, Nunes H, Parent F, Garcia G, Hervé P, Rainisio M, Simonneau G.

    J Am Coll Cardiol. 2002 Aug 21;40(4):780-8.PMID: 12204511 [PubMed - indexed for MEDLINE]Related articles

    11.

    A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group.

    Barst RJ, Rubin LJ, Long WA, McGoon MD, Rich S, Badesch DB, Groves BM, Tapson VF, Bourge RC, Brundage BH, et al.

    N Engl J Med. 1996 Feb 1;334(5):296-302.PMID: 8532025 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Treprostinil-based therapy in the treatment of moderate-to-severe pulmonary arterial hypertension: long-term efficacy and combination with bosentan.

    Benza RL, Rayburn BK, Tallaj JA, Pamboukian SV, Bourge RC.

    Chest. 2008 Jul;134(1):139-45. Epub 2008 Apr 10.PMID: 18403673 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Successful weaning from cardiopulmonary bypass with central venous prostaglandin E1 and left atrial norepinephrine infusion in patients with acute pulmonary hypertension.

    Tritapepe L, Voci P, Cogliati AA, Pasotti E, Papalia U, Menichetti A.

    Crit Care Med. 1999 Oct;27(10):2180-3.PMID: 10548203 [PubMed - indexed for MEDLINE]Related articles

    14.

    Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.

    McLaughlin VV, Genthner DE, Panella MM, Rich S.

    N Engl J Med. 1998 Jan 29;338(5):273-7.PMID: 9445406 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study.

    Humbert M, Sanchez O, Fartoukh M, Jagot JL, Le Gall C, Sitbon O, Parent F, Simonneau G.

    Eur Respir J. 1999 Jun;13(6):1351-6.PMID: 10445611 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial.

    Galiè N, Humbert M, Vachiéry JL, Vizza CD, Kneussl M, Manes A, Sitbon O, Torbicki A, Delcroix M, Naeije R, Hoeper M, Chaouat A, Morand S, Besse B, Simonneau G; Arterial Pulmonary Hypertension and Beraprost European (ALPHABET) Study Group.

    J Am Coll Cardiol. 2002 May 1;39(9):1496-502.PMID: 11985913 [PubMed - indexed for MEDLINE]Related articles

    17.

    Sarcoidosis-associated pulmonary hypertension: outcome with long-term epoprostenol treatment.

    Fisher KA, Serlin DM, Wilson KC, Walter RE, Berman JS, Farber HW.

    Chest. 2006 Nov;130(5):1481-8.PMID: 17099027 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    [Effects of long-term treatment with prostacyclin on plasma adrenomedullin in patients with primary pulmonary hypertension]

    Nakayama T, Ishikita T, Matsuura H, Saji T.

    J Cardiol. 2001 Nov;38(5):263-71. Japanese. PMID: 11729726 [PubMed - indexed for MEDLINE]Related articles

    19.

    Epoprostenol treatment in children with severe pulmonary hypertension.

    Lammers AE, Hislop AA, Flynn Y, Haworth SG.

    Heart. 2007 Jun;93(6):739-43. Epub 2006 Oct 25.PMID: 17065181 [PubMed - indexed for MEDLINE]Related articles

    20.

    Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol.

    Fix OK, Bass NM, De Marco T, Merriman RB.

    Liver Transpl. 2007 Jun;13(6):875-85.PMID: 17539008 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity